HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Minlin Jiang Selected Research

Adenocarcinoma of Lung

1/2021Mechanisms of Progression and Heterogeneity in Multiple Nodules of Lung Adenocarcinoma.
1/2021Tumor Mutation Burden and Differentially Mutated Genes Among Immune Phenotypes in Patients with Lung Adenocarcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Minlin Jiang Research Topics

Disease

16Neoplasms (Cancer)
11/2022 - 01/2020
7Lung Neoplasms (Lung Cancer)
12/2023 - 01/2021
3Neoplasm Metastasis (Metastasis)
06/2021 - 08/2020
3Small Cell Lung Carcinoma (Small Cell Lung Cancer)
02/2021 - 01/2021
2Bites and Stings (Sting)
10/2021 - 01/2020
2Carcinoma (Carcinomatosis)
01/2021 - 12/2020
2Adenocarcinoma of Lung
01/2021 - 01/2021
1Infections
11/2022
1Genomic Instability
10/2021
1Vertigo (Positional Vertigo)
10/2021
1Meniere Disease (Menieres Disease)
10/2021
1Airway Obstruction (Choking)
07/2021
1Pathologic Constriction (Stenosis)
07/2021
1Adenoid Cystic Carcinoma (Cylindroma)
07/2021
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2021
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021
1Adenocarcinoma
01/2021
1Breast Neoplasms (Breast Cancer)
12/2020
1Liver Diseases (Liver Disease)
07/2020
1Hepatitis
07/2020
1Hypoproteinemia
07/2020

Drug/Important Bio-Agent (IBA)

4Biomarkers (Surrogate Marker)IBA
12/2023 - 01/2021
3Immune Checkpoint InhibitorsIBA
01/2021 - 01/2020
3RNA (Ribonucleic Acid)IBA
01/2021 - 01/2021
2Proteins (Proteins, Gene)FDA Link
02/2022 - 04/2021
2cyclic guanosine monophosphate-adenosine monophosphateIBA
10/2021 - 01/2020
2B7-H1 AntigenIBA
10/2021 - 07/2020
2InterferonsIBA
10/2021 - 01/2020
2Small Cytoplasmic RNAIBA
01/2021 - 01/2021
2DNA (Deoxyribonucleic Acid)IBA
01/2021 - 01/2020
1Anti-Bacterial Agents (Antibiotics)IBA
11/2022
1Dermatan SulfateIBA
02/2022
1Racemases and Epimerases (Epimerases and Racemases)IBA
02/2022
1Estrogen Receptor alphaIBA
02/2022
1Volatile Organic CompoundsIBA
11/2021
1AutoantibodiesIBA
11/2021
1Gentamicins (Gentamicin)FDA LinkGeneric
10/2021
1SteroidsIBA
10/2021
1Monoamine Oxidase (MAO)IBA
07/2021
1CateninsIBA
04/2021
1MicroRNAs (MicroRNA)IBA
04/2021
1Keratin-19 (Keratin 19)IBA
04/2021
1Phosphopyruvate Hydratase (Enolase)IBA
04/2021
1Tumor Biomarkers (Tumor Markers)IBA
04/2021
1Cyclin-Dependent Kinase Inhibitor p16IBA
04/2021
1AntigensIBA
04/2021
1PlatinumIBA
02/2021
1CytokinesIBA
01/2021
1HLA-DRB6 antigenIBA
01/2021
1Tyrosine Kinase InhibitorsIBA
01/2021
1ParaffinIBA
01/2021
1Formaldehyde (Formol)FDA Link
01/2021
1Programmed Cell Death 1 ReceptorIBA
01/2021
1HLA Antigens (Human Leukocyte Antigens)IBA
01/2021
1MutS ProteinsIBA
12/2020
1MethyltransferasesIBA
12/2020
1MutL Protein Homolog 1IBA
12/2020
1EnzymesIBA
07/2020
1BilirubinIBA
07/2020
1Cancer VaccinesIBA
01/2020
1CTLA-4 AntigenIBA
01/2020
1AntibodiesIBA
01/2020

Therapy/Procedure

9Therapeutics
12/2023 - 01/2020
8Drug Therapy (Chemotherapy)
11/2022 - 07/2020
8Immunotherapy
11/2022 - 01/2020
1Radiotherapy
12/2020